Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




What are the Benefits and Risks of Fitting Patients With Radiofrequency Identification Devices
Link ID 2006
Title What are the Benefits and Risks of Fitting Patients With Radiofrequency Identification Devices
Url http://www.medscape.com/viewarticle/567776?src=rss
Description Radiofrequency identification devices: what are they? How are they used? What are their advantages related to healthcare? What are the potential unintended risks and ethical concerns for patients?
PLoS Medicine
Category Articles > Business of Medicine
Keywords
Date Jan 2, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. US FDA Clears Wyeth Hemophilia Treatment
  U.S. regulators on Thursday cleared a new drug to treat the blood-clotting disorder hemophilia made by Wyeth Pharmaceuticals. Reuters Health Information
Category:   Articles > Business of Medicine


2. Tiotropium Linked to Possible Increased Risk of Stroke
  On the basis of an ongoing safety review, MedWatch reports a possible increased risk of stroke with use of tiotropium. Medscape Medical News
Category:   Articles > Business of Medicine


3. New Cystic Fibrosis Drug Meets Trial Goal
  A late-stage trial of denufosol, an inhaled cystic fibrosis drug, met the main study goal of significantly improving breathing, Inspire Pharmaceuticals Inc said Friday. Reuters Health Information
Category:   Articles > Business of Medicine


4. WHO Takes Aim at Tobacco Smuggling With New Pact
  Nearly 130 countries have taken the first steps towards a new treaty to combat tobacco smuggling, blamed for higher consumption and up to $50 billion in lost tax revenues each year, officials said on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


5. Trial Into French Growth Hormone Scandal Begins
  Seven French former medical officials went on trial on Wednesday after a 17 year-long investigation into contaminated growth hormones that caused the death of more than 100 people from Creutzfeldt-Jakob disease. The doctors and pharmacists face maximum terms varying from 3 to 10 years if convicted. They face charges of aggravated deception, manslaughter and causing unintentional injury. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS